Literature DB >> 5643071

Virulent and avirulent encapsulated variants of Staphyococcus aureus.

B B Wiley, N H Maverakis.   

Abstract

There are at least two serologically distinct capsular types of coagulase-positive Staphylococcus aureus. Until now, unequivocal evidence for encapsulation of the Smith diffuse variant was lacking. However, the data presented in this paper provide definitive details of encapsulation of the Smith strain. A marked difference in ld(50) values for the two serologically distinct capsular types of S. aureus was demonstrated. The paradoxical behavior of these two strains suggested that the host was resistant to one and was susceptible to the other. A survey of the carriage incidence in mice for staphylococci and staphylococcal capsular antibodies disclosed the presence of staphylococci and capsular antibodies in these animals. The capsular antibodies detected were reactive against only one of the capsular types of S. aureus. None of the sera from the mice surveyed possessed capsular antibodies against the Smith diffuse variant, but the average incidence for the capsular antibodies against the wound mucoid type was 46%. We postulated that the susceptibility of the mice to the Smith diffuse variant was caused by the absence of protective, type-specific capsular antibodies. Conversely, the resistance of the mice to the wound mucoid staphylococci may have been a result of the presence of type-specific capsular antibodies.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5643071      PMCID: PMC252123          DOI: 10.1128/jb.95.3.998-1002.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  14 in total

1.  Pathogenicity of staphylococci; a comparison of alpha-hemolysin production with the coagulase test and clinical observations of virulence.

Authors:  G G JACKSON; H F DOWLING; M H LEPPER
Journal:  N Engl J Med       Date:  1955-06-16       Impact factor: 91.245

2.  A new virulence test for Staphylococcus aureus and its application to encapsulated strains.

Authors:  B B WILEY
Journal:  Can J Microbiol       Date:  1961-12       Impact factor: 2.419

3.  Studies on staphylococci. I. Effect of serum and coagulase on the metabolism of coagulase positive and coagulase negative strains.

Authors:  W W Yotis; R D Ekstedt
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

4.  Isolation of a phagocytosis-inhibiting substance from culture filtrates of an encapsulated Staphylococcus aureus.

Authors:  S I MORSE
Journal:  Nature       Date:  1960-04-02       Impact factor: 49.962

5.  Characteristics of coagulase positive and coagulase negative staphylococci in serum-soft agar.

Authors:  R A FINKELSTEIN; S E SULKIN
Journal:  J Bacteriol       Date:  1958-03       Impact factor: 3.490

6.  A mucoid form of Micrococcus pyogenes var aureus which shows capsular swelling with specific immune serum.

Authors:  K M PRICE; Y KNEELAND
Journal:  J Bacteriol       Date:  1954-04       Impact factor: 3.490

7.  The ultrastructure of encapsulated Diplococcus pneumoniae type 1 before and after exposure to type specific antibody.

Authors:  R F Baker; C G Loosli
Journal:  Lab Invest       Date:  1966-04       Impact factor: 5.662

8.  The importance of surface antigens in staphylococcal virulence.

Authors:  M G Koenig; M A Melly
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

9.  Isolation and properties of a surface antigen of Staphylococcus aureus.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

10.  Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors:  M G KOENIG
Journal:  Yale J Biol Med       Date:  1962-06
View more
  9 in total

1.  Comparison of capsular types of Staphylococcus aureus strains.

Authors:  K Yoshida; Y Naito
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

2.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

3.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.

Authors:  P K Peterson; Y Kim; B J Wilkinson; D Schmeling; A F Michael; P G Quie
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Pseudocompact-type growth and conversion of growth types of strains of Staphylococcus aureus in vitro and in vivo.

Authors:  K Yoshida; M Takahashi; Y Takeuchi
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

5.  Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; P G Quie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

6.  Evidence for a multiplicity of capsular types among Staphylococcus aureus strains.

Authors:  N H Maverakis; B B Wiley
Journal:  J Bacteriol       Date:  1969-08       Impact factor: 3.490

7.  Demonstration of Serologically Different Capsular Types Among Strains of Staphylococcus aureus by the Serum-Soft Agar Technique.

Authors:  K Yoshida
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

8.  Biological and Immunological Properties of Encapsulated Strains of Staphylococcus aureus from Human Sources.

Authors:  K Yoshida; M R Smith; Y Naito
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

9.  Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.